Overview of Restrictive Cardiomyopathies
References
- Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008 Jan;29(2):270-6. doi: 10.1093/eurheartj/ehm342
- McKenna WJ, Maron BJ, Thiene G. Classification, Epidemiology, and Global Burden of Cardiomyopathies. Circ Res. 2017 Sep 15;121(7):722-730. doi: 10.1161/CIRCRESAHA.117.309711
- Pereira NL, Grogan M, Dec GW. Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series. J Am Coll Cardiol. 2018 Mar 13;71(10):1130-1148. doi: 10.1016/j.jacc.2018.01.016
- Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997 Jan 23;336(4):267-76. doi: 10.1056/NEJM199701233360407
- Garcia MJ. Constrictive Pericarditis Versus Restrictive Cardiomyopathy? J Am Coll Cardiol. 2016 May 3;67(17):2061-76. doi: 10.1016/j.jacc.2016.01.076
- Geske JB, Anavekar NS, Nishimura RA, Oh JK, Gersh BJ. Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics. J Am Coll Cardiol. 2016 Nov 29;68(21):2329-2347. doi: 10.1016/j.jacc.2016.08.050
- Galea N, Polizzi G, Gatti M, Cundari G, Figuera M, Faletti R. Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies. Radiol Med. 2020 Nov;125(11):1072-1086. doi: 10.1007/s11547-020-01287-8
- Elliott P, Arbustini E. The role of endomyocardial biopsy in the management of cardiovascular disease: a commentary on joint AHA/ACC/ESC guidelines. Heart. 2009 May;95(9):759-60. doi: 10.1136/hrt.2008.161166
- Casella M, Dello Russo A, Bergonti M, et al. Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies. Circulation. 2020 Sep 29;142(13):1249-1260. doi: 10.1161/CIRCULATIONAHA.120.046900
- Rai TS, Ahmad S, Ahluwalia TS, et al. Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy. Mol Cell Biochem. 2009 Nov;331(1-2):187-92. doi: 10.1007/s11010-009-0157-7
- Anderson HN, Cetta F, Driscoll DJ, Olson TM, Ackerman MJ, Johnson JN. Idiopathic Restrictive Cardiomyopathy in Children and Young Adults. Am J Cardiol. 2018 May 15;121(10):1266-1270. doi: 10.1016/j.amjcard.2018.01.045
- Ammash NM, Seward JB, Bailey KR, Edwards WD, Tajik AJ. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation. 2000 May 30;101(21):2490-6. doi: 10.1161/01.cir.101.21.2490
- Gujja P, Rosing DR, Tripodi DJ, Shizukuda Y. Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol. 2010 Sep 21;56(13):1001-12. doi: 10.1016/j.jacc.2010.03.083
- Crownover BK, Covey CJ. Hereditary hemochromatosis. Am Fam Physician. 2013 Feb 1;87(3):183-90.
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-12.
- Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994 Sep 1;331(9):574-8. doi: 10.1056/NEJM199409013310903
- Liu P, Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther. 1994 Feb;8(1):101-10. doi: 10.1007/BF00877096
- Buja LM, Roberts WC. Iron in the heart. Etiology and clinical significance. Am J Med. 1971 Aug;51(2):209-21. doi: 10.1016/0002-9343(71)90240-3
- Horwitz LD, Rosenthal EA. Iron-mediated cardiovascular injury. Vasc Med. 1999;4(2):93-9. doi: 10.1177/1358836X9900400207
- Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011 Jul;54(1):328-43. doi: 10.1002/hep.24330
- Kremastinos DT, Tsiapras DP, Tsetsos GA, Rentoukas EI, Vretou HP, Toutouzas PK. Left ventricular diastolic Doppler characteristics in beta-thalassemia major. Circulation. 1993 Sep;88(3):1127-35. doi: 10.1161/01.cir.88.3.1127
- Wood JC. Use of magnetic resonance imaging to monitor iron overload. Hematol Oncol Clin North Am. 2014 Aug;28(4):747-64, vii. doi: 10.1016/j.hoc.2014.04.002
- Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011 Nov 15;124(20):2253-63. doi: 10.1161/CIRCULATIONAHA.111.050773
- Caines AE, Kpodonu J, Massad MG, et al. Cardiac transplantation in patients with iron overload cardiomyopathy. J Heart Lung Transplant. 2005 Apr;24(4):486-8. doi: 10.1016/j.healun.2004.02.009
- Morrissey RP, Philip KJ, Schwarz ER. Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy. Cardiovasc J Afr. Jan-Feb 2011;22(1):38-44.
- Mocumbi AO, Stothard JR, Correia-de-Sá P, Yacoub M. Endomyocardial Fibrosis: an Update After 70 Years. Curr Cardiol Rep. 2019 Nov 22;21(11):148. doi: 10.1007/s11886-019-1244-3
- Grimaldi A, Mocumbi AO, Freers J, et al. Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives. Circulation. 2016 Jun 14;133(24):2503-15. doi: 10.1161/CIRCULATIONAHA.115.021178
- Nwokolo C. The evolution of endomyocardial fibrosis. West Afr Med J. 1962 Apr;11:51-7.
- Duraes AR, de Souza Lima Bitar Y, Roever L, Neto MG. Endomyocardial fibrosis: past, present, and future. Heart Fail Rev. 2020 Sep;25(5):725-730. doi: 10.1007/s10741-019-09848-4
- Barretto AC, Mady C, Nussbacher A, et al. Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. Int J Cardiol. 1998 Nov 30;67(1):19-25. doi: 10.1016/s0167-5273(98)00228-9
- León D, Martín M, Corros C, Santamarta E, Costilla S, Lambert JL. Usefulness of cardiac MRI in the early diagnosis of endomyocardial fibrosis. Rev Port Cardiol. 2012 May;31(5):401-2. doi: 10.1016/j.repc.2011.12.016
- Ogbogu PU, Rosing DR, Horne MK
3rd . Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007 Aug;27(3):457-75. doi: 10.1016/j.iac.2007.07.001 - Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994 May 15;83(10):2759-79.
- Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol. 2000 Jul 1;86(1):110-3. doi: 10.1016/s0002-9149(00)00841-9
- Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, Slungaard A. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood. 2006 Jan 15;107(2):558-65. doi: 10.1182/blood-2005-05-2152
- Salanitri GC. Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome. AJR Am J Roentgenol. 2005 May;184(5):1432-3. doi: 10.2214/ajr.184.5.01841432
- Plastiras SC, Economopoulos N, Kelekis NL, Tzelepis GE. Magnetic resonance imaging of the heart in a patient with hypereosinophilic syndrome. Am J Med. 2006 Feb;119(2):130-2. doi: 10.1016/j.amjmed.2005.10.055
- Klion AD. How I treat hypereosinophilic syndromes. Blood. 2015 Aug 27;126(9):1069-77. doi: 10.1182/blood-2014-11-551614
- Moraes F, Lapa C, Hazin S, Tenorio E, Gomes C, Moraes CR. Surgery for endomyocardial fibrosis revisited. Eur J Cardiothorac Surg. 1999 Mar;15(3):309-12; discussion 312-3. doi: 10.1016/s1010-7940(99)00027-5
- Tselios K, Deeb M, Gladman DD, Harvey P, Urowitz MB. Antimalarial-induced cardiomyopathy: a systematic review of the literature. Lupus. 2018 Apr;27(4):591-599. doi: 10.1177/0961203317734922
- Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011 Feb 27;2011:317659. doi: 10.4061/2011/317659
- Madan R, Benson R, Sharma DN, Julka PK, Rath GK. Radiation induced heart disease: Pathogenesis, management and review literature. J Egypt Natl Canc Inst. 2015 Dec;27(4):187-93. doi: 10.1016/j.jnci.2015.07.005
- Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211
- Al-Kindi SG, Oliveira GH. Heart Transplantation Outcomes in Radiation-Induced Restrictive Cardiomyopathy. J Card Fail. 2016 Jun;22(6):475-8. doi: 10.1016/j.cardfail.2016.03.014
DOI: https://doi.org/10.14797/mdcvj.1078 | Journal eISSN: 1947-6108
Language: English
Page range: 4 - 16
Submitted on: Jan 3, 2022
Accepted on: Feb 10, 2022
Published on: Mar 14, 2022
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2022 Smitha Narayana Gowda, Hyeon-Ju Ali, Imad Hussain, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.